Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J E Rubnitz

Showing results (61-70 of 69) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 69 results.
Leukemia|March 21, 2003
Urolithiasis in pediatric patients with acute lymphoblastic leukemiaS C Howard, S D Kaplan, B I Razzouk, et al.
Leukemia|February 24, 2001
Long-term results of Total Therapy studies 11, 12 and 13A for childhood acute lymphoblastic leukemia at St Jude Children's Research HospitalC H Pui, J M Boyett, G K Rivera, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 21, 2017
Infection-related complications during treatment for childhood acute lymphoblastic leukemiaH Inaba, D Pei, J Wolf, et al.
Leukemia|December 17, 2009
Long-term results of St Jude Total Therapy Studies 11, 12, 13A, 13B, and 14 for childhood acute lymphoblastic leukemiaC H Pui, D Pei, J T Sandlund, et al.
Leukemia|June 8, 2011
IDH1 and IDH2 mutations in pediatric acute leukemiaA K Andersson, D W Miller, J A Lynch, et al.
Leukemia|August 26, 2016
Clinical impact of minimal residual disease in children with different subtypes of acute lymphoblastic leukemia treated with Response-Adapted therapyC-H Pui, D Pei, S C Raimondi, et al.
Leukemia|August 27, 2011
ETV6-RUNX1-positive childhood acute lymphoblastic leukemia: improved outcome with contemporary therapyD Bhojwani, D Pei, J T Sandlund, et al.
Clinical Pharmacology and Therapeutics|August 27, 2016
Genomewide Approach Validates Thiopurine Methyltransferase Activity Is a Monogenic Pharmacogenomic TraitC Liu, W Yang, D Pei, et al.
Leukemia|May 1, 2014
A revised definition for cure of childhood acute lymphoblastic leukemiaC H Pui, D Pei, D Campana, et al.
Pageof 7

Showing results (61-70 of 69) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 69 results.
Leukemia|March 21, 2003
Urolithiasis in pediatric patients with acute lymphoblastic leukemiaS C Howard, S D Kaplan, B I Razzouk, et al.
Leukemia|February 24, 2001
Long-term results of Total Therapy studies 11, 12 and 13A for childhood acute lymphoblastic leukemia at St Jude Children's Research HospitalC H Pui, J M Boyett, G K Rivera, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 21, 2017
Infection-related complications during treatment for childhood acute lymphoblastic leukemiaH Inaba, D Pei, J Wolf, et al.
Leukemia|December 17, 2009
Long-term results of St Jude Total Therapy Studies 11, 12, 13A, 13B, and 14 for childhood acute lymphoblastic leukemiaC H Pui, D Pei, J T Sandlund, et al.
Leukemia|June 8, 2011
IDH1 and IDH2 mutations in pediatric acute leukemiaA K Andersson, D W Miller, J A Lynch, et al.
Leukemia|August 26, 2016
Clinical impact of minimal residual disease in children with different subtypes of acute lymphoblastic leukemia treated with Response-Adapted therapyC-H Pui, D Pei, S C Raimondi, et al.
Leukemia|August 27, 2011
ETV6-RUNX1-positive childhood acute lymphoblastic leukemia: improved outcome with contemporary therapyD Bhojwani, D Pei, J T Sandlund, et al.
Clinical Pharmacology and Therapeutics|August 27, 2016
Genomewide Approach Validates Thiopurine Methyltransferase Activity Is a Monogenic Pharmacogenomic TraitC Liu, W Yang, D Pei, et al.
Leukemia|May 1, 2014
A revised definition for cure of childhood acute lymphoblastic leukemiaC H Pui, D Pei, D Campana, et al.
Pageof 7